A Study of Orelabrutinib in Patients With Secondary Progressive Multiple Sclerosis

חו"ל (דורש נסיעה)מגייס משתתפיםPHASE3

מצבים רפואיים

Secondary Progressive Multiple Sclerosis

סיכום בשפה פשוטהבעזרת בינה מלאכותית

הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.

מיקומים
  • Arizona Neuroscience Research, LLC, Phoenix, Arizona, United States

  • Perseverance Research Center, LLC (PRC), Scottsdale, Arizona, United States

  • Fullerton Neurology and Headache Center, Fullerton, California, United States

  • Regina Berkovich MD, PhD Inc, West Hollywood, California, United States

  • SFM Clinical Research, LLC, Boca Raton, Florida, United States

  • Nova Clinical Research, LLC, Bradenton, Florida, United States

  • MS and Neuromuscular Center of Excellence, Clearwater, Florida, United States

  • Neurology Associates, Maitland, Florida, United States

  • Josephson Wallack Munshower Neurology, Pc Suite 225, Indianapolis, Indiana, United States

  • KC Research Center, PA Neurology Research Dept, Roeland Park, Kansas, United States

  • Boston Clinical Trials, Boston, Massachusetts, United States

  • Profound Research LLC at Oakland Neurology Center, Rochester Hills, Michigan, United States

  • Washington University School of Medicine, St Louis, Missouri, United States

  • The Boster Center for Multiple Sclerosis, Columbus, Ohio, United States

  • OMRF Multiple Sclerosis Center of Excellence, Oklahoma City, Oklahoma, United States

  • Premier Neurology, Greenville, South Carolina, United States

  • Lone Star Neurology, San Antonio, Texas, United States

  • Texas Institute for Neurological Disorders - Sherman, Sherman, Texas, United States